Pfizer, Moderna or J&J? An expert answers your questions
Enough COVID-19 vaccine doses are available in the United States that many Americans may now have the freedom of choice.
May 10, 2021
0
13
Enough COVID-19 vaccine doses are available in the United States that many Americans may now have the freedom of choice.
May 10, 2021
0
13
Researchers at the University of Helsinki have identified influenza virus peptides that resemble human protein fragments and can cause an immune response against the body's own cells due to cross-reactivity. The recently ...
Apr 26, 2021
0
6
If someone gets a headache or feels a bit under the weather after receiving a COVID-19 vaccine, it's become common to hear them say something like "Oh, it just means my immune system is really working hard." On the flip side, ...
Apr 19, 2021
0
9
A cytokine 'hurricane' centered in the lungs drives respiratory symptoms in patients with severe COVID-19, a new study by immunologists at Columbia University Vagelos College of Physicians and Surgeons suggests.
Mar 15, 2021
0
216
Scientists from the Institute of Industrial Science at The University of Tokyo demonstrated how the adaptive immune system uses a method similar to reinforcement learning to control the immune reaction to repeat infections. ...
Mar 10, 2021
0
7
As the speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for greater awareness and communication around a delayed injection-site ...
Mar 4, 2021
0
169
In recent years, adeno-associated virus (AAV) has been recognized as the leading vehicle (vector) for in vivo delivery of therapeutic genes because it is non-pathogenic and efficiently targets many different cell and tissue ...
Feb 10, 2021
0
55
Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.
Jan 15, 2021
0
2
Allergic reactions to vaccines are generally rare and people with common allergies are not more likely to have a reaction to the Pfizer-BioNTech COVID-19 vaccine, according to guidance released by the American College of ...
Dec 21, 2020
0
3
Although the vaccine cavalry is finally coming over the hill, the need for better drugs to treat those with COVID-19 remains.
Nov 17, 2020
0
7